*By submitting this form, you authorize NewCrop Rx to contact you with more content and information.
Every year, two million Americans are hospitalized due to adverse drug reactions. Using genomics as a primary tool for individualizing patient care is the future of medicine. Genetic screening can offer a new level of confidence in medication efficacy, and a higher level of patient trust and comfort with treatment decisions.
● Patient Populations and Specialties that Stand to Benefit from Pre-Emptive Pharmacogenomic Testing
● The Importance of PGx Workflow Integration
● High Priced Drugs Where Genomic Testing Can Detect Inefficacy in Advance
● Other Selected Research Excerpts
The ActX mission is to improve health care by making precision medicine practical, thus enabling it to become the standard of care for patients, physicians, and health systems worldwide. We focus on Actionable Genomics℠: evidence-based genetic risks that you can do something about – such as medication use and hereditary risk. During normal prescription workflow, medications are automatically checked for drug genomic interactions, with alerts if there is an issue.
Delivering essential medication and benefits information within the prescribing workflow.
NewCrop PDMP program tracks controlled substance prescriptions in a State providing greater transparency
Send prescriptions for controlled substances securely and electronically from prescriber to pharmacy.
Reduces phone time spent between pharmacy and provider.